Search - tctmd.com

Displaying 21 - 39 of 39

Sort: Relevancy | Date

News Industry News

Edwards Receives IDE for US Clinical Trial of SAPIEN 3 Transcatheter Valve

August 05, 2013

News Industry News

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

May 21, 2013

News Industry News

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

March 11, 2013

News Industry News

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

March 09, 2013

News Industry News

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

October 24, 2012

News Industry News

FDA expands approved use of Sapien artificial heart valve

October 19, 2012

News Industry News

Edwards SAPIEN XT Transcatheter Valve Continues to Achieve Positive Patient Outcomes in 94 Center Post-Approval Study

May 17, 2012

News Industry News

Edwards Lifesciences Files Official Comment on CMS' Proposed TAVR National Coverage Determination

March 04, 2012

News Industry News

TAVI at TCT: Enthusiasm Tempered by Poor Transapical Outcomes

November 09, 2011

News Industry News

Edwards Lifesciences heart valve study halted

November 08, 2011

News Industry News

Real-World TAVI Results Mirror Clinical Trials

November 06, 2011

News Industry News

Echo May Not Provide Best Picture for TAVI

November 06, 2011

News Industry News

Virmani's crystal ball: Transcatheter valves

November 06, 2011

News Industry News

Medtronic’s new direct aortic approach to TAVI wins European approval

November 06, 2011

News Industry News

FDA approves first artificial aortic heart valve placed without open-heart surgery

November 02, 2011

News Industry News

FDA Panel Recommends Approval of Edwards Transcatheter Valve for Treatment of Inoperable Patients

July 20, 2011

News Industry News

FDA Advisory Panel to Review Edwards SAPIEN Valve on July 20

June 07, 2011

News Industry News

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

April 03, 2011

News Industry News

Advertisement

Edwards Receives IDE for US Clinical Trial of SAPIEN 3 Transcatheter Valve

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

FDA expands approved use of Sapien artificial heart valve

Edwards SAPIEN XT Transcatheter Valve Continues to Achieve Positive Patient Outcomes in 94 Center Post-Approval Study

Edwards Lifesciences Files Official Comment on CMS' Proposed TAVR National Coverage Determination

TAVI at TCT: Enthusiasm Tempered by Poor Transapical Outcomes

Edwards Lifesciences heart valve study halted

Real-World TAVI Results Mirror Clinical Trials

Echo May Not Provide Best Picture for TAVI

Virmani's crystal ball: Transcatheter valves

Medtronic’s new direct aortic approach to TAVI wins European approval

FDA approves first artificial aortic heart valve placed without open-heart surgery

FDA Panel Recommends Approval of Edwards Transcatheter Valve for Treatment of Inoperable Patients

FDA Advisory Panel to Review Edwards SAPIEN Valve on July 20

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content